首頁 > 市場調查報告書 > 醫療設備

體外診斷

市場調查報告書

商品編碼

2033420

高成長免疫學測量測試：趨勢、技術和市場機會（2026 年）

High-Growth Immunoassay Tests: Trends, Technologies, and Market Opportunities, 2026

出版日期: 2026年05月07日 | 出版商:

Kalorama Information | 英文 400 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄

儘管許多平台已趨於成熟，但免疫學檢測仍然是體外診斷 (IVD) 領域的重要支柱，為各種臨床檢測應用奠定了基礎。其持續的重要性不僅體現在其跨疾病領域的廣泛應用，也體現在多年來推動其成長和臨床應用的穩步技術進步。本報告「高成長免疫分析儀—趨勢、技術和市場機會，2026」檢驗了免疫學檢測在中心檢查室和即時檢測 (POC) 環境中的現狀及發展趨勢，重點闡述了該領域為何對診斷設備製造商和醫療保健相關人員而言仍具有重要的戰略意義。

市場由廣度和演變所構成

免疫學檢測主要分為兩大類：一類是在中心檢查室進行的大規模檢測，用於篩檢、診斷和病患監測；另一類是在分散式醫療機構中用於類似臨床目的的快速檢測或即時檢測（POC）。這兩類檢測均支持檢測多種分析物，包括蛋白質、抗體、荷爾蒙和藥物。雖然許多檢測方法和平台已經相當成熟，但隨著靈敏度、可靠性和自動化程度的不斷提高，其臨床價值仍在持續成長。

超越成熟：人工智慧驅動的下一代免疫學測量

免疫學檢測技術的最新進展正在改變以往被認為是「成熟市場」的格局。關鍵的創新主題包括多重檢測能力的擴展、支援照護現場平台部署的小型化，以及針對新型生物標記的檢測方法的開發。人工智慧 (AI) 是推動技術成長的主要動力，本報告將深入分析相關的關鍵 AI 趨勢。 AI 透過實現預測性生物標記發現、自動化複雜數據解讀、加速檢測方法最佳化以及支援更複雜的多成分檢測策略，正日益影響免疫學檢測的開發和應用。

分析範圍

本報告對集中檢測系統和照護現場（包括層析法和側向流動檢測）中的免疫學檢測技術進行了全球評估。報告重點關注已開發地區，同時也指出免疫學檢測在檢測基礎設施有限的環境中擴大診斷可及性方面發揮著至關重要的作用。市場分析是基於製造商收入，反映的是檢測數量和使用情況，而非下游定價和報銷趨勢。

調查方法

Kalorama Information的分析是基於嚴謹的一手和二手研究結合的方法。二手研究利用了廣泛的公開和專有資訊來源，以確定市場環境和競爭格局。這些研究結果透過與行業高管、產品經理、醫療保健專業人員、顧問和其他相關人員的深入訪談得到檢驗和完善。所有估算均經過交叉檢驗和三角測量，以確保其一致性和可靠性，預測則基於歷史趨勢、技術創新和全球市場擴張。

戰略意義

隨著免疫學檢測技術的不斷發展，市場呈現出在成熟的臨床可靠性與新興差異化機會之間取得平衡的態勢。人工智慧工具重塑開發平臺和診斷工作流程，尤其推動了這一趨勢。本報告著重分析近期最相關的趨勢，並在必要時參考傳統觀點，為高階決策者提供清晰、最新的免疫學檢測技術現狀展望，以及未來最具成長和創新潛力的領域。

概述 - 免疫學測量
- 化學冷光免疫分析法（CLIA）
- 酵素結合免疫吸附試驗（ELISA）
- 數字ELISA
- 螢光分析（FIA）
- 免疫組織化學（IHC）
- 側向流動免疫測量（LFIA）
- 免疫測量（RIA）
- 西方印漬術
概述 - 測量平台
- 利用微孔板進行免疫學測量和自動化
- 免疫學測量的自動化
- 平台創新：小型化、微流體技術與冗餘
- 照護現場(POC) 和小型設備
- 實驗室晶片（LOC）和生物晶片
檢體類型
- 血
- 尿
- 唾液
- 免疫測量技術的創新

第4章：高成長市場細分（依背景分類）

中央研究所
高成長市場細分
為中央研究實驗室提供行銷服務的公司。
快速檢測和就地檢驗
高成長市場細分
預計檢測設施將經歷高速成長
醫院即時檢測
醫生診所、檢查室辦公室
零售診所
其他專門的即時檢測
自測
一家銷售用於即時檢測（POC）的免疫測定試劑盒的公司。

第5章：免疫診斷測量市場趨勢（按應用領域分類）

高成長市場細分
過敏
高成長產業，包括過敏領域
自體免疫疾病
心臟標記物
基因檢測
感染疾病
- 檢查室進行的感染疾病免疫測定
- 驗血
- 肝炎
- 萊姆病
- 候選疫苗
- 快速檢測和即時檢測
- 逆轉錄病毒
- 性行為感染傳染病
- ToRCH
- COVID-19
- 其他感染疾病
- 高成長感染疾病免疫測定
- 代謝紊亂和其他激素
  - 懷孕、分娩和生殖激素
- 甲狀腺
- 代謝和荷爾蒙等高成長領域
腫瘤學 -腫瘤標記
- 在臨床檢查室進行的腫瘤免疫學測量
- 高成長領域：腫瘤學 -腫瘤標記
毒理學
- 濫用藥物
- 藥物濫用領域的高成長產業
- 治療藥物監測
- TDM領域的高成長領域
免疫檢測疾病市場中其他高成長疾病類別
- 阿茲海默症
- 胃腸道疾病
- 移植管理
- 妊娠高血壓
- 其他特殊免疫學測量

第6章：高成長免疫學測量的市場促進因素與挑戰

高成長免疫學檢測市場概覽
促進因素
任務
相互衝突的影響

第7章免疫學檢測市場分析

市場概況和高成長市場細分
- 按測試點分類的市場規模
- 基於疾病類別的即時免疫學檢測市場
- 整個市場中的疾病細分
- 按技術類型分類的整體市場
- 按地區分類的總市場規模
- 北美洲
- 歐洲
- 亞太地區
- 其他地區
- 新興國際市場
- 競爭分析

第8章：公司簡介

CLIA 和高通量檢測系統
快速和照護現場檢測 (POC)
專用技術和下一代技術
ELISA 和特殊試劑供應商
公司簡介
1 STEP DETECT ASSOCIATES, LLC
ABBOTT LABORATORIES
ABINGDON HEALTH, LTD.
ABNOVA CORP.
ACCESS BIO, INC
ACCUBIOTECH CO, LTD.
ACON LABORATORIES, INC
AESKU. DIAGNOSTICS
AGILENT TECHNOLOGIES
AIDIAN OY
ALFA SCIENTIFIC DESIGNS, INC
AUTOBIO DIAGNOSTICS CO., LTD
BECTON DICKINSON (BD)
BIOMERIEUX SA
BIO-RAD LABORATORIES INC.
BIO-TECHNE
BODITECH MED INC.
BRUKER-CALID
CHEMBIO DIAGNOSTIC SYSTEMS, INC.
CTK BIOTECH, INC.
DANAHER (BECKMAN COULTER, RADIOMETER, HEMOCUE)
Beckman Coulter
DIALAB GMBH
DIASORIN SPA
DIASYS DIAGNOSTIC SYSTEMS GMBH (MINDRAY)
DIAZYME LABORATORIES, INC.
EIKEN CHEMICAL CO LTD.
EKF DIAGNOSTICS HOLDINGS PLC
ELITECHGROUP SAS
EUROIMMUN (GERMANY)
FUJIREBIO-US, INC.
GENBIO
GRIFOLS INTERNATIONAL SA
HOB BIOTECH (CHINA)
HYCOR BIOMEDICAL, INC.
MERIDIAN BIOSCIENCE, INC
MESO SCALE DIAGNOSTICS (MSD)
ORASURE TECHNOLOGIES, INC.
QIAGEN
QUANTERIX CORPORATION
QUIDELORTHO CORPORATION
RANDOX LABORATORIES
REVVITY
ROCHE DIAGNOSTIC CORPORATION
SIEMENS HEALTHINEERS
SNIBE (CHINA)
SPEAR BIO
SYSMEX CORPORATION
THERMO FISHER SCIENTIFIC, INC
TOSOH BIOSCIENCE, INC.
TRINITY BIOTECH PLC

簡介目錄

Product Code: 26-040KA

Immunoassays remain a foundational pillar of the in vitro diagnostics (IVD) landscape, underpinning a broad range of clinical testing applications despite the maturity of many platforms. Their continued relevance reflects both their versatility across disease areas and the steady pace of technological refinement that has sustained growth and clinical adoption over time. This Kalorama Information report, High‑Growth Immunoassay Tests: Trends, Technologies, and Market Opportunities, 2026, examines the current and evolving role of immunoassays across centralized laboratory and point of care (POC) settings, highlighting why the segment remains strategically important for diagnostic manufacturers and healthcare stakeholders.

A Market Defined by Breadth and Evolution

Immunoassays encompass two core segments: high volume testing performed in centralized laboratories for screening, diagnosis, and patient monitoring, and rapid or point of care formats used for similar clinical purposes in decentralized settings. Across both segments, immunoassays support the detection of a wide array of analytes, including proteins, antibodies, hormones, and drugs. While many assays and platforms are well established, ongoing improvements in sensitivity, reliability, and automation continue to reinforce their clinical value.

Innovation Beyond Maturity: AI Driving the Next Phase of Immunoassays

Recent developments in immunoassay technology are reshaping what has traditionally been viewed as a mature market. Key innovation themes include expanded multiplexing capabilities, platform miniaturization to support point of care deployment, and the development of assays targeting novel biomarkers. Because artificial intelligence (AI) is driving much of the technology based growth, this report offers insights into key AI trends wherever relevant. AI is increasingly influencing immunoassay development and use by enabling predictive biomarker discovery, automating complex data interpretation, accelerating assay optimization, and supporting more sophisticated multi analyte detection strategies.

Scope of Analysis

This report provides a global assessment of immunoassay technologies across centralized laboratory systems and point of care formats, including immunochromatographic and lateral flow tests. Coverage emphasizes developed regions while also recognizing the critical role immunoassays play in expanding diagnostic access in settings with limited laboratory infrastructure. Market analysis is based on manufacturer revenues, reflecting testing volumes and utilization rather than downstream pricing or reimbursement dynamics.

Research Approach

Kalorama Information’s analysis is grounded in a rigorous combination of secondary research and primary industry engagement. Secondary research drew from a broad range of public and proprietary sources to establish market context and competitive positioning. These findings were validated and expanded through extensive interviews with industry executives, product managers, healthcare providers, consultants, and other stakeholders. All estimates were cross checked and triangulated to ensure consistency and reliability, with forecasts informed by historical trends, technological innovation, and global market expansion.

Strategic Relevance

As immunoassay technologies continue to evolve, the market reflects a balance between entrenched clinical reliance and emerging opportunities for differentiation—particularly as AI enabled tools reshape development pipelines and diagnostic workflows. This report focuses on the most relevant recent developments, streamlining legacy considerations where appropriate, and provides senior decision makers with a clear, current view of where immunoassays stand and where future growth and innovation are most likely to emerge.

CHAPTER 1: EXECUTIVE SUMMARY

ABOUT KALORAMA INFORMATION
OVERVIEW
SCOPE AND METHODOLOGY
- High Growth Segments
MARKET OVERVIEW
- Table 1-1: Global Immunoassay Market, Highest Growth Segments, 2025 and 2030 (Revenue: $ million) (Share & CAGR: %) [Disease Segment, Region, Technology, Venue]
- Figure 1-1: Global Immunoassay Market, Highest Growth Segments, CAGR 2025-2030 (%) [Disease Segment, Region, Technology, Venue]
COMPETITIVE SUMMARY

CHAPTER 2: INTRODUCTION

HISTORY OF IMMUNOASSAYS
THE FUTURE OF IMMUNOASSAYS
HIGH GROWTH TRENDS

CHAPTER 3: HIGH GROWTH TECHNOLOGY, TRENDS, AND INNOVATIONS

OVERVIEW – IMMUNOASSAYS
- Chemiluminescent Immunoassay (CLIA)
- Enzyme-Linked Immunosorbent Assay (ELISA)
- Digital ELISA
- Fluoroimmunoassay (FIA)
- Immunohistochemistry (IHC)
- Lateral Flow Immunoassay (LFIA)
- Radioimmunoassay (RIA)
- Western Blotting
OVERVIEW – INSTRUMENT PLATFORMS
- Microtiter Plate-Based Immunoassays and Automation
- Automation in Immunoassays
- Platform Innovations: Miniaturization, Microfluidics, and Multiplexing
- Point-of-Care (POC) and Miniaturized Devices
- Lab-on-a-Chip (LOC) and Biochips
SPECIMEN TYPES
- Blood
- Urine
- Saliva
  - Table 3-2: Selected Companies with Saliva or Oral-Fluid Collection Devices
- IMMUNOASSAY TECHNOLOGY INNOVATIONS
  - Table 3-3: Selected Immunoassay Technologies

CHAPTER 4: HIGH GROWTH MARKET SEGMENTS BY SETTING

CENTRALIZED LABORATORIES
- Table 4-1: Global Lab-based Immunoassay Market, by Application Segment, 2025 & 2030 (Revenue: $ million) (Share & CAGR: %) [Allergy, Autoimmune, Cardiac Markers, Genetic, Infectious Disease, Metabolic Disorders and Other Hormones, Toxicology, Tumor Markers, Other]
- Figure 4-1: Global Lab-based Immunoassay Market, by Application Segment, 2025 & 2030 ($ million) [Allergy, Autoimmune, Cardiac Markers, Genetic, Infectious Disease, Metabolic Disorders and Other Hormones, Toxicology, Tumor Markers, Others]
High Growth Market Segments
Companies Marketing to Centralized Laboratories
- Table 4-2: Selected Companies Marketing Central Lab-Based Immunoassays Worldwide
RAPID AND POINT-OF-CARE TESTING
- Table 4-3: Global POC-based Immunoassay Market, by Application Segment, 2025 & 2030 (Revenue: $ million) (Share & CAGR: %) [Cardiac Markers, Hormone/Fertility, Infectious Disease, Oncology (markers and FOBT), Toxicology, Other]
- Figure 4-2: Global POC-based Immunoassay Market, by Application Segment, 2025 & 2030 ($ million) [Cardiac Markers, Hormone/Fertility, Infectious Disease, Oncology (markers and FOBT), Toxicology, Other]
High Growth Market Segments
High Growth Testing Locations
POC Testing in Hospitals
Physician’s Office Laboratories and Clinics
Retail Clinics
Other Professional POC Testing
Self-Testing
Companies Marketing Immunoassay for POC Testing
- Table 4-4: Selected Companies Marketing Immunoassay and/or Lateral Flow Tests for POC Worldwide

CHAPTER 5: IMMUNOASSAY DIAGNOSTIC MARKET ACTIVITY BY APPLICATION

Table 5-1: Global Immunoassay Market, by Disease Segment, 2025 & 2030 (Revenue: $ million) (Share & CAGR: %) [Allergy, Autoimmune, Cardiac Markers, Genetic, Infectious Disease, Metabolic Disorders and Other Hormones, Toxicology, Tumor Markers, Others]
Figure 5-1: Global Immunoassay Market, by Disease Segment, 2025 & 2030 ($ million) [Allergy, Autoimmune, Cardiac Markers, Genetic, Infectious Disease, Metabolic Disorders and Other Hormones, Toxicology, Tumor Markers, Others]

HIGH GROWTH MARKET SEGMENTS
ALLERGY
- Table 5-2: Selected Companies Marketing Immunoassays for Allergy Diagnostics
High Growth Sectors with the Allergy Segment
AUTOIMMUNE DISEASE
- High Growth Sectors with the Autoimmune Segment
CARDIAC MARKERS
- High Growth Sectors with the Cardiac Marker Segment
GENETIC TESTING
- High Growth Sectors with the Genetics Segment
INFECTIOUS DISEASE
- Lab-based Infectious Disease Immunoassays
  - Table 5-6: Global Lab-based Infectious Disease Immunoassay Sales, 2025 & 2030 (Revenue: $ million) (Share & CAGR: %) [Blood banking, C. diff, Hepatitis, HIV, MRSA, Respiratory, STD, Staphylococci, TORCH, Other infectious diseases]
  - Figure 5-2: Global Lab-based Infectious Disease Immunoassay Sales, 2025 & 2030 ($ million) [Blood banking, C. diff, Hepatitis, HIV, MRSA, Respiratory, STD, Staphylococci, TORCH, Other infectious diseases]
  - Table 5-7: Selected Infectious Disease Immunoassays
  - Table 5-8: Selected Companies Marketing Immunoassays for Infectious Disease
- Blood Screening
- Hepatitis
- Lyme Disease
- Vaccine Candidate
- Rapid and POC Testing
- Retroviral
- Sexually Transmitted Diseases
- ToRCH
- COVID-19
  - Table 5-9: Selected Antigen POC and Home Immunoassay Tests for SARS-CoV-2
- Other Infectious Diseases
- High Growth Infectious Disease Immunoassays
- METABOLIC DISORDERS AND OTHER HORMONES
  - Table 5-10: Selected Metabolic and Other Hormone Immunoassays
  - Fertility/Pregnancy/Reproductive Hormones
  - Table 5-11: Selected Fertility and Reproductive Hormone Immunoassays
- Thyroid
  - Table 5-12: Selected Thyroid Hormone Immunoassays
- High Growth Sectors with the Metabolic and Hormone Segment
ONCOLOGY - TUMOR MARKERS
- Lab-based Oncology Immunoassays
  - Table 5-13: Global Lab-based Tumor Marker Immunoassay Sales, 2025 ($ million) [AFP, CA-125, CEA, PSA, Others]
  - Table 5-14: Selected Companies Marketing Immunoassays for Tumor Markers
  - Table 5-15: Selected Companies Marketing Metabolic Immunoassays
- High Growth Sectors with the Oncology – Tumor Marker Segment
TOXICOLOGY
- Drugs of Abuse
  - Table 5-16: Selected Drugs of Abuse Immunoassays
- High Growth Sectors within the Drugs of Abuse Segment
- Therapeutic Drug Monitoring
  - Table 5-17: Selected Therapeutic Drug Monitoring Immunoassays
- High Growth Sectors within the TDM Segment
OTHER HIGH GROWTH DISEASE CATEGORIES IN THE IMMUNOASSAY DISEASE MARKET
- Alzheimer’s Disease
  - Table 5-19: Selected Alzheimer’s Disease Immunoassays
- Gastrointestinal Disorders
  - Table 5-20: Selected Inflammatory Bowel Disease Test Innovations
- Transplant Management
  - Table 5-21: Selected Immunoassays for Transplant Medicine
- Preeclampsia
  - Table 5-22: Selected Women’s Health Innovations
- Other Specialty Immunoassays
  - Table 5-23: Selected Immunoassay Innovations

CHAPTER 6: MARKET DRIVERS AND CHALLENGES FOR HIGH GROWTH IMMUNOASSAYS

HIGH GROWTH IMMUNOASSAY MARKET – OVERVIEW
DRIVERS
- Artificial Intelligence (AI)
- Ultra Sensitivity
- Autonomous Laboratory Operations
- Decentralized POC Systems
- AI-Driven Biomarker Discovery
- Software as a Medical Device
- System-Based Approach
- Federated Learning
- Telehealth Reimbursement
- National Testing Coordination Forum
- Standardization of Host-Response Frameworks
CHALLENGES
- Staffing Shortages
- Regulatory Confusion for Lab-Developed Tests
MIXED EFFECTS
- Geopolitical Tightening
- New Tariffs
- Global Medical Inflation

CHAPTER 7: IMMUNOASSAY MARKET ANALYSIS

MARKET OVERVIEW AND HIGH GROWTH MARKET SEGMENTS
- Total Market by Testing Venue
  - Table 7-2: Global Immunoassay Market, by Venue, 2025 and 2030 (%) (Revenue: $ million) (Share & CAGR: %) [Lab-based, POC-based]
  - Figure 7-2: Global Immunoassay Market, by Venue, CAGR 2025-2030 (%) [Lab-based, POC-based]
- POC Immunoassay Market by Disease Category
  - Table 7-3: Global POC Immunoassay Market, by Disease Category, 2025 and 2030 (Revenue: $ million) (Share & CAGR: %) [Cardiac Markers, Hormone/Fertility, Infectious Disease, Oncology (markers and FOBT), Toxicology, Other]
  - Figure 7-3: Global POC Immunoassay Market, by Disease Category, CAGR 2025-2030 (%) [Cardiac Markers, Hormone/Fertility, Infectious Disease, Oncology (markers and FOBT), Toxicology, Other]
- Total Market Disease Segments
  - Table 7-4: Global Immunoassay Market, by Application Segment, 2025 and 2030 (Revenue: $ million) (Share & CAGR: %) [Allergy, Autoimmune, Cardiac Markers, Genetic, Infectious Disease, Metabolic Disorders and Other Hormones, Toxicology, Tumor Markers, Others]
  - Figure 7-4: Global Immunoassay Market, by Application Segment, CAGR 2025-2030 (%) [Allergy, Autoimmune, Cardiac Markers, Genetic, Infectious Disease, Metabolic Disorders and Other Hormones, Toxicology, Tumor Markers, Others]
- Total Market by Technology Type
  - Table 7-5: Global Immunoassay Market, by Technology, 2025 and 2030 (Revenue: $ million) (Share & CAGR: %) [Chemiluminescent Immunoassay (CLIA), Digital ELISA, Enzyme‑linked Immunosorbent Assay (ELISA), Fluorescence Immunoassay (FIA), Immunohistochemistry (IHC), Lateral Flow Immunoassay (LFIA), Radioimmunoassay (RIA), Western Blot, Other]
  - Figure 7-5: Global Immunoassay Market, by Technology, CAGR 2025-2030 (%) [Chemiluminescent Immunoassay (CLIA), Digital ELISA, Enzyme‑linked Immunosorbent Assay (ELISA), Fluorescence Immunoassay (FIA), Immunohistochemistry (IHC), Lateral Flow Immunoassay (LFIA), Radioimmunoassay (RIA), Western Blot, Other]
- Total Market by Region
  - Table 7-6: Global Immunoassay Market, by Geographic Region, 2025 and 2030 (Revenue: $ million) (Share & CAGR: %) [North America, Europe, Asia Pacific, Rest of World]
  - Figure 7-6: Global Immunoassay Market, by Geographic Region, CAGR 2025–2030 (%) [North America, Europe, Asia Pacific, Rest of World]
- North America
- Europe
  - Table 7-7: Global Immunoassay Market, by European Country, 2025 and 2030 (Revenue: $ million) (Share & CAGR: %) [France, Germany, Italy, Spain, United Kingdom, Others]
  - Figure 7-7: Global Immunoassay Market, by European Country, CAGR 2025-2030 (%) [France, Germany, Italy, Spain, United Kingdom, Others]
- Asia Pacific
  - Table 7-8: Global Immunoassay Market, by Asia Pacific Country, 2025 and 2030 (Revenue: $ million) (Share & CAGR: %) [China, India, Japan, Others]
  - Figure 7-8: Global Immunoassay Market, by Asia Pacific Country, CAGR 2025–2030 (%) [China, India, Japan, Others]
- Rest of World
  - Table 7-9: Global Immunoassay Market, by Rest of World Country, 2025 and 2030 (Revenue: $ million) (Share & CAGR: %) [Brazil, Mexico, Saudi Arabia, South Africa, Turkey, Others]
  - Figure 7-9: Global Immunoassay Market, by Rest of World Country, CAGR 2025–2030 (%) [Brazil, Mexico, Saudi Arabia, South Africa, Turkey, Others]
- Emerging International Markets
  - Table 7-10: Selected Companies Outside of North America, Europe, or Japan Marketing Immunoassays
- COMPETITIVE ANALYSIS
  - Table 7-11: Global Immunoassay Market Analysis, by Competitor Revenues, Product Focus, and Market Share ($ million) (%) [Abbott, Becton Dickinson, Bio‑Rad, bioMérieux, Bruker - CALID, Danaher, DiaSorin, QuidelOrtho, Revvity, Roche, Siemens Healthineers, Thermo Fisher Scientific, Others]
  - Figure 7-10: Global Immunoassay Market Analysis, Share by Competitor Revenues (%) [Abbott, Becton Dickinson, Bio‑Rad, bioMérieux, Bruker - CALID, Danaher, DiaSorin, QuidelOrtho, Revvity, Roche, Siemens Healthineers, Thermo Fisher Scientific, Others]

CHAPTER 8: COMPANY PROFILES

CLIA & HIGH-THROUGHPUT LAB SYSTEMS
RAPID TESTS & POINT-OF-CARE (POC)
- Market Exits: Qualigen
SPECIALIZED & NEXT-GEN TECHNOLOGIES
ELISA & SPECIALTY REAGENT PROVIDERS
COMPANY PROFILES
1 STEP DETECT ASSOCIATES, LLC
- Company Overview
- Products
- Financials
ABBOTT LABORATORIES
- Company Overview
- Products
- Financials
ABINGDON HEALTH, LTD.
- Company Overview
- Products
- Financials
ABNOVA CORP.
- Company Overview
- Products
- Financials
ACCESS BIO, INC
- Company Overview
- Products
- Financials
ACCUBIOTECH CO, LTD.
- Company Overview
- Products
- Financials
ACON LABORATORIES, INC
- Company Overview
- Products
- Financials
AESKU. DIAGNOSTICS
- Company Overview
- Products
- Financials
AGILENT TECHNOLOGIES
- Company Overview
- Products
- Financials
AIDIAN OY
- Company Overview
- Products
- Financials
ALFA SCIENTIFIC DESIGNS, INC
- Company Overview
- Products
- Financials
AUTOBIO DIAGNOSTICS CO., LTD
- Company Overview
- Products
- Financials
BECTON DICKINSON (BD)
- Company Overview
- Products
- Financials
BIOMÉRIEUX SA
- Company Overview
- Products
- Financials
BIO-RAD LABORATORIES INC.
- Company Overview
- Products
- Financials
BIO-TECHNE
- Company Overview
- Products
- Financials
BODITECH MED INC.
- Company Overview
- Products
- Financials
BRUKER-CALID
- Company Overview
- Products
- Financials
CHEMBIO DIAGNOSTIC SYSTEMS, INC.
- Company Overview
- Products
- Financials
CTK BIOTECH, INC.
- Company Overview
- Products
- Financials
DANAHER (BECKMAN COULTER, RADIOMETER, HEMOCUE)
- Company Overview
- Products
- Beckman Coulter
- Radiometer
- HemoCue
- Financials
DIALAB GMBH
- Company Overview
- Products
- Financials
DIASORIN S.P.A.
- Company Overview
- Products
- Financials
DIASYS DIAGNOSTIC SYSTEMS GMBH (MINDRAY)
- Company Overview
- Products
- Financials
DIAZYME LABORATORIES, INC.
- Company Overview
- Products
- Financials
EIKEN CHEMICAL CO LTD.
- Company Overview
- Products
- Financials
EKF DIAGNOSTICS HOLDINGS PLC
- Company Overview
- Products
- Financials
ELITECHGROUP S.A.S.
- Company Overview
- Products
- Financials
EUROIMMUN (GERMANY)
- Company Overview
- Products
- Financials
FUJIREBIO-US, INC.
- Company Overview
- Products
- Financials
GENBIO
- Company Overview
- Products
- Financials
GRIFOLS INTERNATIONAL S.A.
- Company Overview
- Products
- Financials
HOB BIOTECH (CHINA)
- Company Overview
- Products
- Financials
HYCOR BIOMEDICAL, INC.
- Company Overview
- Products
- Financials
MERIDIAN BIOSCIENCE, INC
- Company Overview
- Products
- Financials
MESO SCALE DIAGNOSTICS (MSD)
- Company Overview
- Products
- Financials
ORASURE TECHNOLOGIES, INC.
- Company Overview
- Products
- Financials
QIAGEN
- Company Overview
- Products
- Financials
QUANTERIX CORPORATION
- Company Overview
- Products
- Financials
QUIDELORTHO CORPORATION
- Company Overview
- Products
- Financials
RANDOX LABORATORIES
- Company Overview
- Products
- Financials
REVVITY
- Company Overview
- Products
- Financials
ROCHE DIAGNOSTIC CORPORATION
- Company Overview
- Products
- Financials
SIEMENS HEALTHINEERS
- Company Overview
- Products
- Financials
SNIBE (CHINA)
- Company Overview
- Products
- Financial
SPEAR BIO
- Company Overview
- Products
- Financial
SYSMEX CORPORATION
- Company Overview
- Products
- Financials
THERMO FISHER SCIENTIFIC, INC
- Company Overview
- Products
- Financials
TOSOH BIOSCIENCE, INC.
- Company Overview
- Products
- Financials
TRINITY BIOTECH PLC
- Company Overview
- Products
- Financials